{"id":304841,"date":"2024-05-17T18:32:03","date_gmt":"2024-05-17T18:32:03","guid":{"rendered":"https:\/\/healthmedicinet.com\/i\/novel-genetic-mechanisms-may-serve-as-therapeutic-target-against-glioma\/"},"modified":"2024-05-17T18:32:03","modified_gmt":"2024-05-17T18:32:03","slug":"novel-genetic-mechanisms-may-serve-as-therapeutic-target-against-glioma","status":"publish","type":"post","link":"http:\/\/healthmedicinet.com\/i\/novel-genetic-mechanisms-may-serve-as-therapeutic-target-against-glioma\/","title":{"rendered":"Novel genetic mechanisms may serve as therapeutic target against glioma"},"content":{"rendered":"<p>Graphical abstract. Journal of Clinical Investigation (2024) https:\/\/doi.org\/10.1172\/JCI173789 A study from the laboratory of Shi-Yuan Cheng, Ph.D., professor in the Ken and Ruth Davee Department of Neurology&#8217;s Division of Neuro-oncology, has identified novel mechanisms underlying RNA splicing events within glioma tumor cells, mechanisms which may serve as novel therapeutic targets, according to findings published in the Journal of Clinical Investigation. &#8220;We found another way to treat glioma through the alternative splicing perspective, and we found some novel targets which have not been identified before but are important for glioma malignancy,&#8221; <a class=\"read-more-link\" href=\"https:\/\/healthmedicinet.com\/novel-genetic-mechanisms-may-serve-as-therapeutic-target-against-glioma\/\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Graphical abstract. Journal of Clinical Investigation (2024) https:\/\/doi.org\/10.1172\/JCI173789 A study from the laboratory of Shi-Yuan Cheng, Ph.D., professor in the Ken and Ruth Davee Department of Neurology&#8217;s Division of Neuro-oncology, has identified novel mechanisms underlying RNA splicing events within glioma tumor cells, mechanisms which may serve as novel therapeutic targets, according to findings published in <a class=\"read-more-link\" href=\"http:\/\/healthmedicinet.com\/i\/novel-genetic-mechanisms-may-serve-as-therapeutic-target-against-glioma\/\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-304841","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/posts\/304841","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/comments?post=304841"}],"version-history":[{"count":0,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/posts\/304841\/revisions"}],"wp:attachment":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/media?parent=304841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/categories?post=304841"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/tags?post=304841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}